
Eprex 4000 Injection
Marketer
Janssen Pharmaceuticals
Salt Composition
Recombinant Human Erythropoietin Alfa (4000IU/0.4ml)
Overview Eprex 4000 Injection
Aranesp 4000 Injection stimulates red blood cell production in the bone marrow. It's indicated for anemia stemming from kidney failure, cancer chemotherapy, or HIV medications. Administration, either subcutaneous or intravenous, is determined by your physician and typically performed by a medical professional. Dosage is tailored to your weight and the underlying cause of your anemia. Concurrent iron supplementation can enhance treatment efficacy. The injection should be refrigerated but brought to room temperature before use. Common side effects include nausea, vomiting, pyrexia, and hypertension; flu-like symptoms (headache, fatigue, vertigo, myalgia) are also possible, often subsiding with continued treatment. Report any severe adverse events, including convulsions, immediately. Serious thromboembolic complications necessitate immediate medical care. Prior to treatment, disclose any history of uncontrolled hypertension, cardiac disease, or gout. Inform your doctor about all other medications you are taking due to potential interactions. Regular blood pressure monitoring and other laboratory tests are essential to track treatment effects. The drug's impact on fetal development is unknown; inform your doctor about pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Eprex 4000 Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of Eprex 4000 Injection
Managing Anemia in Cancer Chemotherapy Patients | Addressing Anemia Associated with Chronic Kidney Disease
Major Benefits of Eprex 4000 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Eprex 4000 Injection:
- High blood pressure
- Nausea
- Vomiting
- Fever
- Rash
- Joint pain
- Headache
- Insomnia (difficulty in sleeping)
- Chills
- Cough
- Bone pain
- Muscle spasm
- Dizziness
- Vascular occlusion
- Injection site irritation
- Stomatitis (Inflammation of the mouth)
- Weight loss
- Decreased white blood cell count (lymphocytes)
- Increased glucose level in blood
- Blood clot in the blood vessels
How to use Eprex 4000 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Eprex 4000 Injection works:
Darbepoetin alfa injection (Eprex 4000) boosts red blood cell production. This erythropoiesis-stimulating agent acts on the bone marrow, the blood cell-producing tissue within bones, to increase red blood cell count.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Eprex 4000 Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Aranesp 4000 Injection may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Eprex 4000 Injection while breastfeeding is likely inadvisable. Available evidence from human studies indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Using Eprex 4000 Injection might lead to adverse reactions that could impair driving ability.
KidneySAFE IF PRESCRIBED
Aranesp 4000 Injection poses no safety concerns for individuals with renal impairment; dosage modification isn't necessary. Routine assessment of renal function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Aranesp 4000 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Eprex 4000 Injection :
Should you forget a scheduled Eprex 4000 Injection, seek your physician's advice.
Facts to Know About Eprex 4000 Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
